Position in AZN
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$141,266
New position
Shares Held
745
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#1,217
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MB, LEVIS & ASSOCIATES, LLC holds $6,723,211 across 10 Drug Manufacturers - General names. AZN ranks #6 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
10,703 | $2,718,240 | |
| 2 | MRK |
Merck & Co., Inc.
|
11,732 | $1,507,562 | |
| 3 | AMGN |
Amgen Inc
|
2,928 | $1,060,287 | |
| 4 | NVS |
Novartis AG
|
5,410 | $847,855 | |
| 5 | LLY |
ELI LILLY & Co
|
125 | $149,928 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
745 | $141,266 | |
| 7 | ABBV |
AbbVie Inc.
|
547 | $137,647 | |
| 8 | PFE |
Pfizer Inc
|
3,886 | $93,574 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $141,266 | 745 | Shares | Sole | 2026-07-22 | |
| No filing history on record for this holder in this stock. | ||||||